Onset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b Trial

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Annie Burden (Creator)
Giorgio Walter Canonica (Creator)
Pascal Chanez (Creator)
Borja Cosio (Creator)
Tim Harrison (Creator)
Renaud Louis (Creator)
Njira Lugogo (Creator)
Lawrence Mcdermott (Creator)
Francesco Menzella (Creator)
Arjun Mohan (Creator)
Institution
East Carolina University (ECU )
Web Site: http://www.ecu.edu/lib/

Additional Information

Publication
Other
Language: English
Date: 2023
Subjects
eosinophilic asthma;benralizumab;lung function

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Onset of Effect and Impact on Health-Related Quality of Life, Exacerbation Rate, Lung Function, and Nasal Polyposis Symptoms for Patients with Severe Eosinophilic Asthma Treated with Benralizumab (ANDHI): a Randomised, Controlled, Phase 3b Trialhttp://hdl.handle.net/10342/11522The described resource references, cites, or otherwise points to the related resource.